Clincosm LogoSign in Get a demo

relapsed ovarian cancer

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

Not yet recruiting
  • Relapsed Ovarian Cancer
  • (no location specified)
Oct 7, 2023

Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemo, Platinum Sensitive Trial in China,

Active, not recruiting
  • Relapsed Ovarian Cancer
  • +2 more
  • Olaparib 300mg tablets
  • Beijing, China
  • +24 more
Dec 5, 2022

Relapsed Ovarian Cancer Trial in Hangzhou (Secondary cytoreduction, Chemotherapy)

Recruiting
  • Relapsed Ovarian Cancer
  • Hangzhou, Zhejiang, China
    Women's Hospital, Zhejiang University School of Medicine
Nov 4, 2022

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Ovarian Tumors, Recurrent Ovarian Carcinoma, Relapsed Ovarian Cancer Trial in Beijing (AK112 low dose, AK112 medium dose, AK112

Terminated
  • Ovarian Neoplasms
  • +3 more
  • AK112 low dose
  • +2 more
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
Oct 8, 2022

Relapsed Ovarian Cancer Trial (Fluzoparib+Apatinib, Fluzoparib Monotherapy)

Not yet recruiting
  • Relapsed Ovarian Cancer
  • (no location specified)
Jul 27, 2022

Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])

Recruiting
  • Platinum-sensitive Ovarian Cancer
  • Relapsed Ovarian Cancer
  • OSE2101
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Angers, France
  • +27 more
Jul 25, 2022

Relapsed Ovarian Cancer Trial in Hangzhou (Fluzoparib+Apatinib, Fluzoparib)

Recruiting
  • Relapsed Ovarian Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 25, 2021

Trabectedin + PLD in Treatment of Relapsed Ovarian Cancer

Completed
Has Results
  • Relapsed Ovarian Cancer
  • Aalst, Flandes, Belgium
  • +64 more
Sep 30, 2021

Relapsed Ovarian Cancer Trial in Roma (PLD and Trabectedin rechallenge)

Recruiting
  • Relapsed Ovarian Cancer
  • PLD and Trabectedin rechallenge
  • Roma, Italy
    Fondazione Policlinico Gemelli IRCCS
Aug 5, 2021